By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Compugen Ltd. 

72 Pinchas Rosen Street

Tel Aviv    69512  Israel
Phone: 972-3-765-8585 Fax: 972-3-765-8555


Company News
Compugen Ltd. (CGEN) Announces Issuance Of U.S. Patent For COM701, Its Lead Immuno-Oncology Product Candidate 7/25/2017 6:54:11 AM
Compugen Ltd. (CGEN) Second Quarter 2017 Conference Call Scheduled For Wednesday, August 2, 2017 At 10:00 AM ET 7/24/2017 11:23:02 AM
Compugen Ltd. (CGEN) Presents At ASCO COM701 Drug Combination Data With TIGIT And PD-1 Inhibitors In Preclinical Models 6/5/2017 9:26:44 AM
Compugen Ltd. (CGEN) Provides Update On COM701 And Upcoming Presentations 5/31/2017 11:17:48 AM
Compugen Ltd. (CGEN) Announces Appointment Of Dr. Michal Preminger To Board Of Directors 5/25/2017 7:46:40 AM
Compugen Ltd. (CGEN) To Present At Two Upcoming Investor Conferences In June 5/23/2017 11:32:59 AM
Compugen Ltd. (CGEN) Reports First Quarter 2017 Results 5/9/2017 7:34:23 AM
Compugen Ltd. (CGEN) To Present COM701 Checkpoint Product Candidate For Immuno-Oncology At ASCO 5/4/2017 9:26:28 AM
Compugen Ltd. (CGEN) First Quarter 2017 Conference Call Scheduled For Tuesday, May 9, 2017 At 10:00 AM ET 4/26/2017 11:01:06 AM
Compugen Ltd. (CGEN) Announces Lead Therapeutic Candidate COM902 For CGEN-15137/TIGIT Immuno-Oncology Program 3/28/2017 11:57:43 AM